亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Outcomes of Goniotomy With or Without Secondary Intraocular Lens Implantation in Pediatric Glaucoma Following Cataract Surgery: A Prospective Pilot Study

医学 四分位间距 眼压 青光眼 前瞻性队列研究 眼科 白内障手术 继发性青光眼 人工晶状体 外科
作者
Yu Zhang,Wan Chen,Tse‐Chun Lin,Xiulan Zhang,Dennis S.C. Lam,Weirong Chen
出处
期刊:Asia-Pacific journal of ophthalmology [Lippincott Williams & Wilkins]
卷期号:12 (5): 444-450 被引量:2
标识
DOI:10.1097/apo.0000000000000637
摘要

Purpose: To report the outcomes of a 120-degree goniotomy (GT) with or without secondary intraocular lens (IOL) implantation in glaucoma following cataract surgery (GFCS). Design: Prospective, observational study. Methods: Pediatric patients with GFCS who underwent standalone 120-degree GT or 120-degree GT combined with secondary IOL implantation (GT+IOL) from March 2022 to August 2022 at the Zhongshan Ophthalmic Center were recruited. Primary outcomes were intraocular pressure (IOP) and the number of ocular hypotensive medications. A secondary outcome was the surgical success rate. Success was defined as a postoperative IOP within the range of 5–21 mm Hg. Complete and qualified successes were defined, as the above, without and with ocular hypotensive medications, respectively. Results: Thirty-two eyes of 22 patients were included. The mean age at the time of GT was 68.5 ± 29.3 months. The mean follow-up duration was 12.2 ± 2.3 months (9–15 mo). Mean IOP decreased from 30.9 ± 4.8 mm Hg on 2 (interquartile range = 1) medications at baseline to 15.8 ± 3.6 mm Hg on 0 (interquartile range = 1.5) medication at the latest visit in all eyes. The overall complete and qualified success rates were 68.8% and 90.6%, respectively. There were no significant differences in IOP, number of medications, and complete and qualified success rates between the standalone GT and GT+IOL groups at the latest follow-up at 9 months postoperatively. Conclusions: To reduce the need for additional surgery, 120-degree GT was a safe and effective surgical treatment for GFCS in children, which could be combined with secondary IOL implantation in aphakic eyes with GFCS.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ccj发布了新的文献求助10
1秒前
英姑应助yuanyuan采纳,获得50
2秒前
心行完成签到 ,获得积分10
4秒前
oleskarabach完成签到,获得积分20
4秒前
俊逸翠柏完成签到 ,获得积分10
7秒前
bellapp完成签到 ,获得积分10
7秒前
12秒前
沉默的延恶完成签到,获得积分10
13秒前
笨笨的怜雪完成签到 ,获得积分10
33秒前
36秒前
36秒前
上官若男应助科研通管家采纳,获得10
38秒前
orixero应助科研通管家采纳,获得10
38秒前
科研通AI2S应助科研通管家采纳,获得10
38秒前
21度多云完成签到,获得积分10
45秒前
51秒前
trophozoite完成签到 ,获得积分10
1分钟前
1分钟前
橘子发布了新的文献求助10
1分钟前
qiuqiu完成签到 ,获得积分10
1分钟前
量子星尘发布了新的文献求助10
1分钟前
1分钟前
SCIfafafafa发布了新的文献求助10
1分钟前
hua完成签到,获得积分10
1分钟前
于是乎完成签到 ,获得积分10
1分钟前
bkagyin应助大力的图图采纳,获得10
1分钟前
所所应助SCIfafafafa采纳,获得10
1分钟前
LZR发布了新的文献求助10
1分钟前
科目三应助迅速初柳采纳,获得10
1分钟前
个木完成签到,获得积分10
1分钟前
1分钟前
yanglinhai完成签到 ,获得积分10
1分钟前
慕青应助可靠的寒风采纳,获得10
1分钟前
luckydog发布了新的文献求助10
1分钟前
1分钟前
eclo完成签到 ,获得积分10
2分钟前
2分钟前
2分钟前
周墨完成签到 ,获得积分10
2分钟前
2分钟前
高分求助中
2025-2031全球及中国金刚石触媒粉行业研究及十五五规划分析报告 40000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Introduction to strong mixing conditions volume 1-3 5000
Agyptische Geschichte der 21.30. Dynastie 3000
Les Mantodea de guyane 2000
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 2000
„Semitische Wissenschaften“? 1510
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5746419
求助须知:如何正确求助?哪些是违规求助? 5434098
关于积分的说明 15355366
捐赠科研通 4886387
什么是DOI,文献DOI怎么找? 2627215
邀请新用户注册赠送积分活动 1575696
关于科研通互助平台的介绍 1532425